Operating profit before deduction of amortization: Astria Therapeutics, Inc. (ATXS)
The stability of the biomedical sector amid global disputes provides Astria Therapeutics (ATXS) with a neutral backdrop. The company's operating profit on the GURU.Markets daily chart reflects market expectations, where 0.00 is recorded as the baseline value. Growth prospects rely on the commercialization of therapy for hATTR, although financial risks are linked to potential clinical trial failures and capital shortages.
Astria Therapeutics, Inc. (ATXS) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio Astria Therapeutics|ATXS - Long-Term Debt to Capital|Current Liabilities to Capital Astria Therapeutics Inc|ATXS - Company Aggregate Debts|Debts to Book Capitalization Astria Therapeutics|ATXS - Company Long-Term Debt|Short-Term Debt Volume Astria Therapeutics|Intermediate Liquidity Ratio astriatx.com
- earnings and multiples data:
ATXS - Company Net Income|Expected Net Income Astria Therapeutics|ATXS - P/E Multiple|Market Cap to Projected Earnings astriatx.com|ATXS - PEG Multiple|EV/EBITDA Multiple Astria Therapeutics|ATXS - Operating profit before deduction of amortization|Earnings per share for the trailing year Astria Therapeutics|ATXS - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months astriatx.com|ATXS - Earnings growth in current year|Expected earnings per share trend next year Astria Therapeutics
Summary company analytics:ATXS (Astria Corp)
Inelastic demand for the STAR-0215 drug provides Astria Therapeutics (ATXS) with significant pricing power, directly impacting cash flow. This projected EBITDA level quantifies this potential by measuring the net cash balance from operating activities excluding taxes and depreciation, allowing investors to assess the real efficiency of the business and avoid overpaying for the asset.
Competitors of Astria Therapeutics (ATXS)
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics, Inc.|Operating profit before deduction of amortization IMVT|Operating profit EBITDA Kiniksa Corp|Profit before payment of interest, taxes and amortization Grifols, S.A. (GRFS)|adaptivebiotech.com - Operating profit before amortization|Operating profit EBITDA CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Profit before interest, taxes and amortization|BioCryst Pharmaceuticals Inc - Operating profit EBITDA|VERA - Operating profit EBITDA|Dianthus Therapeutics (DNTH) - Profit before payment of interest, taxes and amortization|PHVS - Operating income before deduction of amortization|Operating profit before deduction of amortization ABCL|TRML (Tourmaline Bio Inc) - Company profit before taxes, interest and amortization|Profit before payment of interest, taxes and amortization Intrexon (PGEN)|PHAR (Pharming Corp) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA NKTR (Nektar Therapeutics)|Operating income before deduction of amortization upstreambio.com (UPB)|Zenas Biopharma - Operating profit EBITDA|IMNM - Operating profit EBITDA|GOSS (Gossamer Corp) - Operating profit before deduction of amortization|KalVista Corp - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization SEPN|PVLA (pieris.com) - Company profit before taxes, interest and amortization|Operating profit EBITDA SVRA|RIGL (Rigel Pharma) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA ANAB (AnaptysBio Corp)|enGene Corp (ENGN) - Profit before interest, taxes and amortization|RAPT - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization JBIO (Aerovate Therapeutics Inc)|ACRS: Operating profit EBITDA|Kyverna Therapeutics Inc. (KYTX) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Tiziana Life Sciences PLC|Cabaletta Bio Inc - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA VTYX|THTX - Profit before interest, taxes and amortization|Avalo Therapeutics - Operating profit before deduction of amortization|Operating profit EBITDA Eledon Pharmaceuticals Inc. ELDN|AGEN: Operating profit before deduction of amortization|Climb Bio, Inc - Company profit before taxes, interest and amortization|ZURA: Operating profit EBITDA|ATYR - Operating income before deduction of amortization|ADAG (Adagene Inc) - Operating profit EBITDA|Operating profit before deduction of amortization Ikena Oncology, Inc. (IMA)|Profit before payment of interest, taxes and amortization Shattuck Labs, Inc. (STTK)|Operating income before deduction of amortization equilliumbio.com|Operating profit EBITDA CNTB (Connect Biopharma Holdings Limited)|Operating profit EBITDA Immunic Therapeutics IMUX|ATRA: Operating profit before deduction of amortization|InflaRx N.V. - Company profit before taxes, interest and amortization|XFOR (X4 Pharma) - Operating profit before deduction of amortization|Operating profit before amortization ACET|Profit before payment of interest, taxes and amortization Celularity Inc|inmunebio.com (INMB) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Barinthus Biotherapeutics plc (BRNS)|KZR: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA SABS (SAB Biotherapeutics, Inc)|Income before deduction of interest, taxes and amortization AKTX|Enlivex Therapeutics, Ltd. - Operating profit EBITDA|QTTB - Operating profit EBITDA|GeoVax (GOVX) - Profit before payment of interest, taxes and amortization|Edesa Biotech Inc - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization iBio Corp|Operating profit before deduction of amortization Carisma Tx (CARM)|Operating profit EBITDA XTLB|Operating profit EBITDA boltbio.com (BOLT)|HCW Biologics - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization APVO|AIM ImmunoTech Inc. - Operating profit EBITDA|Operating income before deduction of amortization Aditxt ADTX|GRI Bio, Inc. (GRI) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization xortx.com|Profit before payment of interest, taxes and amortization Vyome Holdings|Operating profit before deduction of amortization Revelation Biosciences Inc (REVB)|Operating profit before deduction of amortization INDP (Indaptus)|Operating profit EBITDA BiondVax Pharmaceuticals (SCNI)|Profit before payment of interest, taxes and amortization CalciMedica CALI|AFMD: Operating profit before amortization|Allakos Therapeutics - Operating profit EBITDA|Profit before interest, taxes and amortization HOOKIPA Pharma Inc.|IGMS: Operating profit EBITDA|iTeos Pharma (ITOS) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Ocean Biomedical, Inc.|tcbiopharm.com (TCBP) - Operating income before deduction of amortization|Operating profit before deduction of amortization THRD (Third Harmonic Bio, Inc.)
